igf-1 lr3 dosierung (1mg) – Alpha BioMed Recombinant Human LR3 IGF-I/IGF-1 GMP

10.1038/sj.onc.1208940 Oncogene 139 NzouG.WicksR

& DePinho, R

As GOT1/2 dKO cancer cells form tumors normally, we next aimed to elucidate how the-se cells adapt to GOT1/2 deficiency

Primary antibodies used were p53 (CST, #9282, 1:1000 dilution), phospho-p53 (CST, #9284, 1:1000 dilution), p21 (CST, #2947, 1:1000 dilution), phospho-histone H2A.X (CST, #9718, 1:1000 dilution), phospho-CHK1 (CST, #2348, 1:500 dilution), phospho-CHK2 (CST, #2661, 1:500 dilution), Vinculin (Santa Cruz, #sc-73614, 1:2000 dilution), alpha-tubulin (CST, #2144, 1:2000 dilution), and beta-actin (Santa Cruz, #sc-47778, 1:2000 dilution)

In consideration of the importance of Alzheimers disease in Japan, we believe it is imperative that such pathways be established